Ilorasertib (hydrochloride), CAS [[1847485-91-9]]

Produktübersicht

• Artikelname: Ilorasertib (hydrochloride), CAS [[1847485-91-9]]
• Artikelnummer: MCE-HY-16018A
• Hersteller Artikelnummer: HY-16018A
• Alternativnummer: MCE-HY-16018A-25MG,MCE-HY-16018A-10MMX1ML,MCE-HY-16018A-5MG,MCE-HY-16018A-10MG,MCE-HY-16018A-1MG,MCE-HY-16018A-100MG,MCE-HY-16018A-50MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: ABT-348 (hydrochloride)

Produktbeschreibung

Ilorasertib (ABT-348) hydrochloride is a potent, orally active and ATP-competitive aurora inhibitor with IC50s of116, 5, 1 nM for aurora A, aurora B, aurora C, respectively. Ilorasertib hydrochloride also is a potent VEGF, PDGF inhibitor. Ilorasertib hydrochloride has the potential for the research of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)[1][2].

Produkteigenschaften

• Molekulargewicht: 525.00
• Reinheit: 98.48
• CAS Nummer: [1847485-91-9]
• Formel: C25H22ClFN6O2S
• Target-Kategorie: Aurora Kinase,PDGFR,VEGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound